A team from the San Diego Supercomputer Center at UC San Diego contributed to a study led by the Vanderbilt Vaccine Center on T cell receptors, which play a vital role in alerting the adaptive immune system to mount an attack on invading foreign pathogens, including Coronavirus SARS-CoV-2.
J. Silvio Gutkind, PhD, has been named chair of the Department of Pharmacology at UC San Diego School of Medicine.
Project focuses on lipids (fat molecules) as the starting point to understand the evolution of eukaryotic cells, carrying implications for human health and disease
Two University of California San Diego researchers have received prestigious awards through the 2020 National Institutes of Health (NIH) High-Risk, High-Reward Research Program.
The University of California San Diego’s Holocaust Living History Workshop (HLHW) is returning this fall with a yearlong series of seven lectures that underscore the theme “Witnessing the Past: Holocaust Histories.”
Patients receiving care for advanced cancer at Moores Cancer Center at UC San Diego Health were more likely to survive or experience a longer period without their disease progressing if they received personalized cancer therapy.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
